Aquestive Therapeutics, Inc. 10-K filing
Filed 2026-03-04 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001398733-26-000018
- Form type
- 10-K
- CIK
- 0001398733
- Primary document
- https://www.sec.gov/Archives/edgar/data/1398733/000139873326000018/aqst-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aquestive Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $44.5M | - | - |
| Cost Of Revenue | $18.6M | - | - |
| Operating Income | $-71.1M | - | - |
| Net Income | $-83.8M | - | - |
| Eps Basic | -0.78 | - | - |
| Eps Diluted | -0.78 | - | - |
| Total Assets | $160.4M | - | - |
| Total Liabilities | $194.1M | - | - |
| Shareholders Equity | $-33.7M | - | - |
| Operating Cash Flow | $-52.4M | - | - |
| Capital Expenditures | $562,000 | - | - |